Literature DB >> 14398978

Ocular changes in Graves' disease. A long-term follow-up study.

I B HALES, F F RUNDLE.   

Abstract

Entities:  

Keywords:  EYE/diagnosis; HYPERTHYROIDISM/diagnosis

Mesh：

Year:  1960        PMID： 14398978

Source DB:  PubMed          Journal:  Q J Med        ISSN： 0033-5622


× No keyword cloud information.
  23 in total

1.  Histopathologic analysis of palpebral conjunctiva in thyroid-related orbitopathy (an american ophthalmological society thesis).

Authors:  Don O Kikkawa
Journal:  Trans Am Ophthalmol Soc       Date:  2010-12

2.  Recurrent external ophthalmoparesis during hormonal therapy after thyroid ablation. Case report.

Authors:  F Ferracci; F Conte; B Marini; G Fassetta
Journal:  Ital J Neurol Sci       Date:  1997-08

Review 3.  Graves orbitopathy: a perspective.

Authors:  Petros Perros; Gerasimos E Krassas
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

4.  Somatostatin-receptor scintigraphy in Graves' orbitopathy.

Authors:  P T Postema; D J Kwekkeboom; P M van Hagen; E P Krenning
Journal:  Eur J Nucl Med       Date:  1996-06

5.  Imaging biomarkers in thyroid eye disease and their clinical associations.

Authors:  Shikha Chaganti; Katrina Nelson; Kevin Mundy; Robert Harrigan; Robert Galloway; Louise A Mawn; Bennett Landman
Journal:  J Med Imaging (Bellingham)       Date:  2018-10-16

Review 6.  Immunosuppressant therapy of thyroid eye disease.

Authors:  G Kahaly; J Beyer
Journal:  Klin Wochenschr       Date:  1988-11-01

7.  Ocular manifestations of Graves' disease: therapeutic approaches.

Authors:  R M Day
Journal:  Bull N Y Acad Med       Date:  1977-04

8.  Heterogeneity of failure of visual acuity in Graves' disease.

Authors:  Y Sachdev; J C Chatterji; R C Sharma
Journal:  Postgrad Med J       Date:  1979       Impact factor: 2.401

Review 9.  Prevalence and natural history of Graves' orbitopathy in the XXI century.

Authors:  E Piantanida; M L Tanda; A Lai; L Sassi; L Bartalena
Journal:  J Endocrinol Invest       Date:  2013-04-16       Impact factor: 4.256

10.  Long-term effect of triamcinolone acetonide in the treatment of upper lid retraction with thyroid associated ophthalmopathy.

Authors:  Dong-Dong Xu; Yu Chen; Hai-Yan Xu; Hui Li; Zhu-Hua Zhang; Yu-Hua Liu
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.